Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aideen M Sullivan

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Neuronal Signaling|July 28, 2020
<i>Neuronal Signaling</i>: an introductionAideen M Sullivan
Progress in Neurobiology|June 28, 2008
Progress in Parkinson's disease-where do we stand?André Toulouse, Aideen M Sullivan
Cytokine & Growth Factor Reviews|June 22, 2011
Neurotrophic factors for the treatment of Parkinson's diseaseAideen M Sullivan, André Toulouse
The European Journal of Neuroscience|August 14, 2018
Trophic factors for Parkinson's disease: Where are we and where do we go from here?Gesine Paul, Aideen M Sullivan
Neural Regeneration Research|April 14, 2016
Neurotrophic factor therapy for Parkinson's disease: past, present and futureAideen M Sullivan, Gerard W O'Keeffe
Neuroscience Letters|August 29, 2007
Expression of the cell surface markers mAb 2F7 and PSA-NCAM in the embryonic rat brainDaniel K Shanley, Aideen M Sullivan
Brain Research|November 5, 2005
Alterations in cellular phenotypes differentiating from embryonic rat brain neurosphere cultures by immunoselection of neuronal progenitorsDaniel K Shanley, Aideen M Sullivan
Neuronal Signaling|February 15, 2021
<i>Neuronal Signaling</i>: A reflection on the Biochemical Society's newest journal and an exciting outlook on its next stepsAideen M Sullivan, S Clare Stanford
Parkinsonism & Related Disorders|June 24, 2018
Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's diseaseGerard W O'Keeffe, Aideen M Sullivan
Journal of Anatomy|September 28, 2005
The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatmentAideen M Sullivan, Gerard W O'Keeffe
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Neuronal Signaling|July 28, 2020
<i>Neuronal Signaling</i>: an introductionAideen M Sullivan
Progress in Neurobiology|June 28, 2008
Progress in Parkinson's disease-where do we stand?André Toulouse, Aideen M Sullivan
Cytokine & Growth Factor Reviews|June 22, 2011
Neurotrophic factors for the treatment of Parkinson's diseaseAideen M Sullivan, André Toulouse
The European Journal of Neuroscience|August 14, 2018
Trophic factors for Parkinson's disease: Where are we and where do we go from here?Gesine Paul, Aideen M Sullivan
Neural Regeneration Research|April 14, 2016
Neurotrophic factor therapy for Parkinson's disease: past, present and futureAideen M Sullivan, Gerard W O'Keeffe
Neuroscience Letters|August 29, 2007
Expression of the cell surface markers mAb 2F7 and PSA-NCAM in the embryonic rat brainDaniel K Shanley, Aideen M Sullivan
Brain Research|November 5, 2005
Alterations in cellular phenotypes differentiating from embryonic rat brain neurosphere cultures by immunoselection of neuronal progenitorsDaniel K Shanley, Aideen M Sullivan
Neuronal Signaling|February 15, 2021
<i>Neuronal Signaling</i>: A reflection on the Biochemical Society's newest journal and an exciting outlook on its next stepsAideen M Sullivan, S Clare Stanford
Parkinsonism & Related Disorders|June 24, 2018
Evidence for dopaminergic axonal degeneration as an early pathological process in Parkinson's diseaseGerard W O'Keeffe, Aideen M Sullivan
Journal of Anatomy|September 28, 2005
The role of growth/differentiation factor 5 (GDF5) in the induction and survival of midbrain dopaminergic neurones: relevance to Parkinson's disease treatmentAideen M Sullivan, Gerard W O'Keeffe
Pageof 9